Hui Zhang

机构：Fujian Medical University, Army Medical University, Xian Center for Disease Control and Prevention, Wuhan Institute of Virology, Southwest Hospital, Fujian Provincial Cancer Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-8251-8983

发表论文 37 篇 · 总被引 443 次 · h-index 8

代表论文

• Development of a prognostic score for recommended TACE candidates with hepatocellular carcinoma: A multicentre observational study (2019 · Journal of Hepatology · 被引 269)
• Global prevalence of asymptomatic norovirus infection in outbreaks: a systematic review and meta-analysis (2023 · BMC Infectious Diseases · 被引 24)
• Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis (2020 · Hepatobiliary & pancreatic diseases international · 被引 18)
• Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolization (2022 · European Radiology · 被引 15)
• Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆ (2024 · JHEP Reports · 被引 11)
• Asymptomatic norovirus infection during outbreaks in China: A systematic review and meta‐analysis (2024 · Journal of Medical Virology · 被引 6)